SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?


To: Michael Young who wrote (299)9/3/2002 10:08:13 AM
From: rkrw  Respond to of 508
 
I agree. A 40% survival advantage was impressive and not trivial at all. I think the cited short sellers are naive about IPF and its treatment alternatives. 2002/2003 sales projections are looking safe which should bode well.